Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients

Myocardial Ischemia Secondary to Synthetic Cannabinoid (K2) Use in Pediatric Patients

K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern f...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Journal of pediatrics 2015-09, Vol.167 (3), p.757-761.e1
Hauptverfasser: Clark, Bradley C., MD, Georgekutty, Justin, MD, Berul, Charles I., MD
Format: Artikel
Sprache:eng
Schlagworte:
Adolescent
Cannabinoids - adverse effects
Designer Drugs - adverse effects
Electrocardiography
Humans
Male
Myocardial Ischemia - chemically induced
Pediatrics
Tachycardia, Sinus - chemically induced
Troponin I - blood
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:K2 is a synthetic cannabinoid that has potential cardiovascular side effects, including myocardial ischemia, myocardial infarction, and arrhythmias. Cardiac testing of pediatric patients is often not performed owing to a lack of symptomatology. We report a series of pediatric patients with concern for myocardial ischemia temporally associated with K2 exposure.
ISSN:0022-3476
1097-6833
DOI:10.1016/j.jpeds.2015.06.001